These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 22011244)

  • 1. Hypoxia activated prodrugs of a 9-aza-anthrapyrazole derivative that has promising anticancer activity.
    El-Dakdouki MH; Adamski N; Foster L; Hacker MP; Erhardt PW
    J Med Chem; 2011 Dec; 54(23):8224-7. PubMed ID: 22011244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antitumor evaluation of bis aza-anthracene-9,10-diones and bis aza-anthrapyrazole-6-ones.
    Antonini I; Santoni G; Lucciarini R; Amantini C; Dal Ben D; Volpini R; Cristalli G
    J Med Chem; 2008 Feb; 51(4):997-1006. PubMed ID: 18232651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor potential of aza-bioisosterism in anthracenedione-based drugs.
    Sissi C; Palumbo M
    Curr Top Med Chem; 2004; 4(2):219-30. PubMed ID: 14754455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel N-oxide of naphthalimides as prodrug leads against hypoxic solid tumor: synthesis and biological evaluation.
    Yin H; Xu Y; Qian X; Li Y; Liu J
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2166-70. PubMed ID: 17331719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New anthracenedione derivatives with improved biological activity by virtue of stable drug-DNA adduct formation.
    Mansour OC; Evison BJ; Sleebs BE; Watson KG; Nudelman A; Rephaeli A; Buck DP; Collins JG; Bilardi RA; Phillips DR; Cutts SM
    J Med Chem; 2010 Oct; 53(19):6851-66. PubMed ID: 20860366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationships of 1,5-diazaanthraquinones as antitumour compounds.
    Avendaño C; Pérez JM; Blanco Mdel M; de la Fuente JA; Manzanaro S; Vicent MJ; Martín MJ; Salvador-Tormo N; Menéndez JC
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3929-32. PubMed ID: 15225700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of stable, water soluble radicals as potential anti-cancer agents.
    Lattmann E; Begum A; Plater MJ
    Drug Des Discov; 1999 Nov; 16(3):195-201. PubMed ID: 10624565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological activity of N-2,3-dihydroxypropyl-N-4-chlorobutyl nucleoside phosphoramidate prodrugs.
    Wu W; Borch RF
    Mol Pharm; 2006; 3(4):451-6. PubMed ID: 16889439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual targeting of hypoxic and acidic tumor environments with a cobalt(III) chaperone complex.
    Yamamoto N; Renfrew AK; Kim BJ; Bryce NS; Hambley TW
    J Med Chem; 2012 Dec; 55(24):11013-21. PubMed ID: 23199008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro optimization of non-small cell lung cancer activity with troxacitabine, L-1,3-dioxolane-cytidine, prodrugs.
    Radi M; Adema AD; Daft JR; Cho JH; Hoebe EK; Alexander LE; Peters GJ; Chu CK
    J Med Chem; 2007 May; 50(9):2249-53. PubMed ID: 17419604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regioselective synthesis and in vitro anticancer activity of 4-aza-podophyllotoxin derivatives catalyzed by L-proline.
    Shi C; Wang J; Chen H; Shi D
    J Comb Chem; 2010 Jul; 12(4):430-4. PubMed ID: 20503973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and one-electron reduction characteristics of radiation-activated prodrugs possessing two 5-fluorodeoxyuridine units.
    Tanabe K; Sugiura M; Ito T; Nishimoto S
    Bioorg Med Chem; 2012 Sep; 20(17):5164-8. PubMed ID: 22847019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of novel bis-anthraquinone derivatives and their biological evaluation as antitumor agents.
    Taher AT; Hegazy GH
    Arch Pharm Res; 2013 May; 36(5):573-8. PubMed ID: 23471561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-paclitaxel conjugates as drug delivery system: synthesis, self-assembly property, drug release, and antitumor activity.
    Wang Y; Xin D; Liu K; Zhu M; Xiang J
    Bioconjug Chem; 2009 Dec; 20(12):2214-21. PubMed ID: 19950889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, DNA binding, and cytotoxicity studies of pyrrolo[2,1-c][1,4]benzodiazepine-anthraquinone conjugates.
    Kamal A; Ramu R; Tekumalla V; Khanna GB; Barkume MS; Juvekar AS; Zingde SM
    Bioorg Med Chem; 2007 Nov; 15(22):6868-75. PubMed ID: 17822905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antiproliferative activity of 1,4-bis(dimethylamino)-9,10-anthraquinone derivatives against P388 mouse leukemic tumor cells.
    Jin GZ; Jin HS; Jin LL
    Arch Pharm Res; 2011 Jul; 34(7):1071-6. PubMed ID: 21811913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
    Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
    J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in-vitro cytotoxicity evaluation of novel naphtindolizinedione derivatives, part II: improved activity for aza-analogues.
    Defant A; Guella G; Mancini I
    Arch Pharm (Weinheim); 2009 Feb; 342(2):80-6. PubMed ID: 19173337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between structure and antiproliferative activity of 1-azaflavanones.
    Kawaii S; Endo K; Tokiwano T; Yoshizawa Y
    Anticancer Res; 2012 Jul; 32(7):2819-25. PubMed ID: 22753743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on quinones. Part 44: Novel angucyclinone N-heterocyclic analogues endowed with antitumoral activity.
    Valderrama JA; Colonelli P; Vásquez D; González MF; Rodríguez JA; Theoduloz C
    Bioorg Med Chem; 2008 Dec; 16(24):10172-81. PubMed ID: 19013074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.